Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecularly targeted therapeutics for breast cancer.
Hussain SA, Palmer DH, Spooner D, Rea DW. Hussain SA, et al. Among authors: rea dw. BioDrugs. 2007;21(4):215-24. doi: 10.2165/00063030-200721040-00002. BioDrugs. 2007. PMID: 17628119 Review.
Coagulopathic complications in breast cancer.
Caine GJ, Stonelake PS, Rea D, Lip GY. Caine GJ, et al. Cancer. 2003 Oct 15;98(8):1578-86. doi: 10.1002/cncr.11702. Cancer. 2003. PMID: 14534872 Free article. Review.
Endocrine therapy for early breast cancer.
Hussain SA, Williams S, Stevens A, Rea DW. Hussain SA, et al. Among authors: rea dw. Expert Rev Anticancer Ther. 2004 Oct;4(5):877-88. doi: 10.1586/14737140.4.5.877. Expert Rev Anticancer Ther. 2004. PMID: 15485321 Review.
Role of chemotherapy in breast cancer.
Hussain SA, Palmer DH, Stevens A, Spooner D, Poole CJ, Rea DW. Hussain SA, et al. Among authors: rea dw. Expert Rev Anticancer Ther. 2005 Dec;5(6):1095-110. doi: 10.1586/14737140.5.6.1095. Expert Rev Anticancer Ther. 2005. PMID: 16336100 Review.
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
Poole CJ, Earl HM, Hiller L, Dunn JA, Bathers S, Grieve RJ, Spooner DA, Agrawal RK, Fernando IN, Brunt AM, O'Reilly SM, Crawford SM, Rea DW, Simmonds P, Mansi JL, Stanley A, Harvey P, McAdam K, Foster L, Leonard RC, Twelves CJ; NEAT Investigators and the SCTBG. Poole CJ, et al. Among authors: rea dw. N Engl J Med. 2006 Nov 2;355(18):1851-62. doi: 10.1056/NEJMoa052084. N Engl J Med. 2006. PMID: 17079759 Free article. Clinical Trial.
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life.
Earl HM, Hiller L, Dunn JA, Bathers S, Harvey P, Stanley A, Grieve RJ, Agrawal RK, Fernando IN, Brunt AM, McAdam K, O'Reilly S, Rea DW, Spooner D, Poole CJ; NEAT Investigators. Earl HM, et al. Among authors: rea dw. Br J Cancer. 2008 Oct 21;99(8):1226-31. doi: 10.1038/sj.bjc.6604674. Epub 2008 Sep 16. Br J Cancer. 2008. PMID: 18797468 Free PMC article. Clinical Trial.
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
Ellis P, Barrett-Lee P, Johnson L, Cameron D, Wardley A, O'Reilly S, Verrill M, Smith I, Yarnold J, Coleman R, Earl H, Canney P, Twelves C, Poole C, Bloomfield D, Hopwood P, Johnston S, Dowsett M, Bartlett JM, Ellis I, Peckitt C, Hall E, Bliss JM; TACT Trial Management Group; TACT Trialists. Ellis P, et al. Lancet. 2009 May 16;373(9676):1681-92. doi: 10.1016/S0140-6736(09)60740-6. Lancet. 2009. PMID: 19447249 Free PMC article. Clinical Trial.
139 results